Averywell Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Averywell General Information

Description

Developer of screening technology designed for early lung cancer detection and lung nodule management. The company develops a non-invasive, precise, and cost-effective miRNA-based liquid biopsy technology by seamlessly integrating artificial intelligence and machine learning, enabling healthcare providers to make lung cancer testing highly reliable, convenient, and accessible through a simple blood test.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rutherford House, Manchester Science Park
  • 40 Pencroft Way
  • Manchester M15 6SZ
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Corporate Office
  • Rutherford House, Manchester Science Park
  • 40 Pencroft Way
  • Manchester M15 6SZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Averywell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator Completed Generating Revenue
8. Seed Round 16-Apr-2024 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Seed Round 17-Oct-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Jul-2022 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Averywell’s complete valuation and funding history, request access »

Averywell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Ordinary
To view Averywell’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Averywell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of screening technology designed for early lung cancer detection and lung nodule management. The company devel
Diagnostic Equipment
Manchester, United Kingdom
2 As of 2025

Heidelberg, Germany
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Averywell Competitors (5)

One of Averywell’s 5 competitors is Hummingbird Diagnostics, a Venture Capital-Backed company based in Heidelberg, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hummingbird Diagnostics Venture Capital-Backed Heidelberg, Germany
Oncimmune Formerly VC-backed Cambridge, MA
Biodesix Formerly VC-backed Louisville, CO
GRAIL Formerly VC-backed Menlo Park, CA
Guardant Health Formerly VC-backed Palo Alto, CA
You’re viewing 5 of 5 competitors. Get the full list »

Averywell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Averywell Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Genesis Ventures (Greece) Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
Accelerate ME Accelerator/Incubator
Alderley Park Accelerator/Incubator
Barclays Eagle Lab Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Averywell FAQs

  • When was Averywell founded?

    Averywell was founded in 2021.

  • Where is Averywell headquartered?

    Averywell is headquartered in Manchester, United Kingdom.

  • What is the size of Averywell?

    Averywell has 2 total employees.

  • What industry is Averywell in?

    Averywell’s primary industry is Diagnostic Equipment.

  • Is Averywell a private or public company?

    Averywell is a Private company.

  • What is Averywell’s current revenue?

    The current revenue for Averywell is .

  • How much funding has Averywell raised over time?

    Averywell has raised $433K.

  • Who are Averywell’s investors?

    Genesis Ventures (Greece), MedTech Innovator, Accelerate ME, Alderley Park, and Barclays Eagle Lab are 5 of 8 investors who have invested in Averywell.

  • Who are Averywell’s competitors?

    Hummingbird Diagnostics, Oncimmune, Biodesix, GRAIL, and Guardant Health are competitors of Averywell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process